MedImmune Inc., Japan Tobacco, Kyowa Hakko Kogyo Ltd. deal

Japan Tobacco granted MEDI exclusive worldwide rights, excluding Japan, to develop and commercialize a MAb against inducible-costimulator

Read the full 177 word article

How to gain access

Continue reading with a
two-week free trial.